You are here

  • Home
  • Archive
  • Volume 13, Issue 4
  • Letter by Tang et al regarding the article ‘Leukoaraiosis and acute ischemic stroke: 90-day clinical outcome following endovascular recanalization, with proposed “L-ASPECTS”’

Article info

Article menu

This article has a Reply. Please see:

Download PDFPDF
Letter
Letter by Tang et al regarding the article ‘Leukoaraiosis and acute ischemic stroke: 90-day clinical outcome following endovascular recanalization, with proposed “L-ASPECTS”’

Authors

  • Xiaojia Tang Neurology, Dalian Medical University, Dalian, Liaoning Province, China Neurology, Yangzhou University Affiliated Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, China PubMed articlesGoogle scholar articles
  • Yuhan Luo Neurology, Dalian Medical University, Dalian, Liaoning Province, China Neurology, Yangzhou University Affiliated Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, China PubMed articlesGoogle scholar articles
  • Peipei Liu Neurology, Yangzhou University Affiliated Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, China Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China PubMed articlesGoogle scholar articles
  • Yingzhu Chen Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Peipei Liu; doclpp87{at}163.com; Dr Yingzhu Chen; yzchendr{at}163.com
View Full Text

Citation

Tang X, Luo Y, Liu P, et al
Letter by Tang et al regarding the article ‘Leukoaraiosis and acute ischemic stroke: 90-day clinical outcome following endovascular recanalization, with proposed “L-ASPECTS”’
Journal of NeuroInterventional Surgery 2021;13:e7.

Publication history

  • Received August 27, 2020
  • Accepted September 13, 2020
  • First published October 6, 2020.
Online issue publication 
March 15, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.